Based on data from the past 90 days ending January 09, 2026, Agios Pharmaceuticals's three largest insider shareholders are Director Jacqualyn A Fouse (151.34K shares), Chief Executive Officer Brian Goff (143.10K shares), Director David P Schenkein (126.24K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Jacqualyn A Fouse | 151,340 | 23 Jun, 2025 | |
| Brian Goff | Chief Executive Officer | 143,103 | 02 Jan, 2026 |
| David P Schenkein | 126,242 | 17 Jun, 2024 | |
| Sarah Gheuens | Chief Medical Officer | 64,795 | 02 Jan, 2026 |
| Cecilia Jones | Chief Financial Officer | 37,394 | 02 Jan, 2026 |
| Tsveta Milanova | Chief Commercial Officer | 34,793 | 07 Jan, 2026 |
| James William Burns | Chief Legal Officer | 31,718 | 02 Jan, 2026 |
| John Maraganore | 30,028 | 24 May, 2022 | |
| Jonathan Biller | Chief Financial Officer | 22,953 | 23 Feb, 2022 |
| David Scadden | 17,603 | 14 Nov, 2025 | |
| Maykin Ho | 17,032 | 23 Jun, 2025 | |
| Bruce Car | Chief Scientific Officer | 16,752 | 23 Feb, 2022 |
| Christopher Bowden | Chief Medical Officer | 15,487 | 22 Jun, 2021 |
| Cynthia Smith | 12,414 | 13 Aug, 2025 | |
| Rahul D. Ballal | 12,414 | 13 Aug, 2025 | |
| Richa Poddar | Chief Commercial Officer | 8,508 | 18 Oct, 2022 |
| Kaye I Foster-Cheek | 7,468 | 23 Jun, 2025 | |
| Darrin Miles | Chief Commercial Officer | 7,209 | 18 May, 2021 |
| Paul J Clancy | 6,549 | 24 May, 2022 | |
| Ian T Clark | 6,549 | 24 May, 2022 | |
| Jeffrey D Capello | 6,073 | 23 Jun, 2025 | |
| Adams Catherine Owen | 6,073 | 23 Jun, 2025 | |
| Theodore James Jr. Washburn | Principal Accounting Officer | 868 | 09 Sep, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 05 Jan, 2026 | Tsveta Milanova | Common stock | D | 2,872 | $27.02 | 34,793 | D | S |
| 05 Jan, 2026 | Tsveta Milanova | Common stock | A | 8,475 | $0.00 | 37,665 | D | M |
| 30 Dec, 2025 | Brian Goff | Common stock | A | 25,528 | $0.00 | 149,056 | D | M |
| 30 Dec, 2025 | Brian Goff | - | - | 143,103 | D | |||
| 30 Dec, 2025 | Brian Goff | Common stock | D | 6,230 | $27.09 | 143,103 | D | S |
| 30 Dec, 2025 | Brian Goff | Common stock | A | 12,750 | $0.00 | 149,333 | D | M |
| 30 Dec, 2025 | Brian Goff | - | - | 149,056 | D | |||
| 30 Dec, 2025 | Brian Goff | - | - | 136,583 | D | |||
| 30 Dec, 2025 | Brian Goff | - | - | 149,333 | D | |||
| 30 Dec, 2025 | Brian Goff | Common stock | D | 12,473 | $27.09 | 136,583 | D | S |
| 30 Dec, 2025 | Cecilia Jones | Common stock | D | 2,932 | $27.09 | 37,394 | D | S |
| 30 Dec, 2025 | Cecilia Jones | Common stock | A | 6,000 | $0.00 | 40,326 | D | M |
| 30 Dec, 2025 | Sarah Gheuens | Common stock | A | 6,000 | $0.00 | 67,727 | D | M |
| 30 Dec, 2025 | Sarah Gheuens | Common stock | D | 2,932 | $27.09 | 64,795 | D | S |
| 30 Dec, 2025 | James William Burns | Common stock | A | 6,000 | $0.00 | 34,650 | D | M |
| 30 Dec, 2025 | James William Burns | Common stock | D | 2,932 | $27.09 | 31,718 | D | S |
| 30 Dec, 2025 | Tsveta Milanova | Common stock | D | 2,932 | $27.09 | 29,190 | D | S |
| 30 Dec, 2025 | Tsveta Milanova | Common stock | A | 6,000 | $0.00 | 32,122 | D | M |
| 12 Nov, 2025 | David Scadden | Common stock | D | 200 | $43.84 | 17,603 | D | S |
| 12 Nov, 2025 | David Scadden | Common stock | A | 200 | $18.09 | 17,803 | D | M |